| Literature DB >> 21356392 |
K Kitajima1, K Murakami, Y Kaji, S Sakamoto, K Sugimura.
Abstract
Integrated positron emission tomography/computed tomography (PET/CT) with 2-[¹⁸F]fluoro-2-deoxy-D-glucose (FDG) is a useful technique to acquire both glucose metabolic and anatomic imaging data using a single device in a single diagnostic session and has opened a new field in clinical oncologic imaging. FDG-PET/CT has been used successfully for the staging, optimization of treatment, re-staging, therapy monitoring, and prognostic prediction of uterine cervical cancer and endometrial cancer as well as various malignant tumours. The present review discusses the current role of FDG-PET/CT in the management of uterine cancer, discussing its usefulness and limitations in the imaging of these patients.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21356392 DOI: 10.1016/j.crad.2010.07.012
Source DB: PubMed Journal: Clin Radiol ISSN: 0009-9260 Impact factor: 2.350